Trial Profile

An Open-label, Randomized, Single-dose, Two-way Crossover Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of IMP4297 Capsules in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 21 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Senaparib (Primary)
Indications Prostate cancer; Small cell lung cancer; Solid tumours
Focus Pharmacokinetics
Sponsors IMPACT Therapeutics

Most Recent Events

14 Oct 2022 Results evaluating the effect of food on the pharmacokinetics of senaparib in healthy Chinese subjects, published in the Clinical Drug Investigation
26 Mar 2020 Status changed from recruiting to completed.
19 Aug 2019 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com